MedPath

ECG Belt for CRT Response

Not Applicable
Completed
Conditions
Heart Failure
Registration Number
NCT03504020
Lead Sponsor
Medtronic Cardiac Rhythm and Heart Failure
Brief Summary

The purpose of this clinical study is to compare ECG Belt Research System managed cardiac resynchronization therapy (CRT) patients and a control CRT group with respect to left ventricular (LV) remodeling.

Detailed Description

The ECG Belt study is a prospective, interventional, randomized, multi-center, investigational, pre-market research study. The ECG Belt Research System will be used at implant and follow-up to help implanters choose a suitable LV pacing site within the recommended locations for LV lead implantation and optimize pacing vector/timing parameters.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
498
Inclusion Criteria
  • Indicated for CRT, with QRS duration ≥130 ms, and planned to be implanted with a market-released Medtronic CRT device with AdaptivCRT and a Medtronic quadripolar LV lead.
  • Meets at least one of the following criteria: QRS duration < 150 ms, Prior documented Myocardial Infarction, Non-LBBB
  • LVEDD ≥ 55 mm, as determined by site
Exclusion Criteria
  • Permanent/persistent AF or presenting with AF
  • Pre-existing or previous LV lead or other confounding devices e.g. Left Ventricular Assist Device, Vagal Nerve Stimulator
  • Currently implanted with IPG or ICD with > 10% RV pacing
  • Permanent complete AV block
  • Enrolled in a concurrent study that may confound the results of this study. Pre-approval from the study manager is required for enrollment of a patient that is in a concurrent study.
  • Less than 1 year life expectancy
  • Vulnerable adults
  • Younger than 18 years of age

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in Left Ventricular End Systolic Volume (LVESV) From Baseline to 6 Months Post-implant.baseline to 6 months

Relative (%) change in LVESV from the baseline measurement to the 6 month measurement.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (43)

Hartford Hospital

🇺🇸

Hartford, Connecticut, United States

Yale School of Medicine

🇺🇸

New Haven, Connecticut, United States

MedStar Washington Hospital Center

🇺🇸

Washington, District of Columbia, United States

University of Florida Health Shands Hospital

🇺🇸

Gainesville, Florida, United States

Florida Hospital Cardiovascular Research Institute

🇺🇸

Orlando, Florida, United States

BayCare Health System

🇺🇸

Tampa, Florida, United States

NorthShore University Health System

🇺🇸

Evanston, Illinois, United States

Iowa Heart Center

🇺🇸

West Des Moines, Iowa, United States

Heartland Cardiology

🇺🇸

Wichita, Kansas, United States

Cardiovascular Institute of the South

🇺🇸

Houma, Louisiana, United States

Scroll for more (33 remaining)
Hartford Hospital
🇺🇸Hartford, Connecticut, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.